Table 2 Inspection during the process from onset to identification of the pathogens
Inspection | result |
|---|---|
2023.12.18 | Â |
 Influenza A virus antigen | Positive |
2023.12.28 | Â |
 Blood cryptococcus antigen | negative |
 Blood culture | negative |
 T-SPOT.TB | negative |
 Sputum Culture | negative |
 Xpert mtb/rif (Sputum) | negative |
2023.12.29 | Â |
 Influenza A virus nucleic acid | Positive |
 Influenza B virus nucleic acid | negative |
2019-nCoV antigen | negative |
 Legionella pneumophila antibody IgM | negative |
 Mycoplasma pneumoniae antibody IgM | negative |
 Chlamydia pneumoniae antibody IgM | negative |
 Adenovirus antibody IgM | negative |
 Respiratory syncytial virus antibody IgM | negative |
 Acid-fast smear (Sputum) | negative |
 Serum (1–3)- β- D-glucan (pg/ml) | 42 |
 Serum galactomannan | 0.07 |
 Cytomegalovirus nucleic acid (/ml) | < 102 |
 Epstein-Barr virus nucleic acid (/ml) | < 4 × 102 |
2024.1.1 | Â |
 Mycoplasma pneumoniae nucleic acid | negative |
2024.1.3 | Â |
 Bronchoscopy | inflammatory in the right lower lobe bronchitis |
 Influenza A virus nucleic acid | negative |
 BALF Culture | negative |
 Xpert mtb/rif (BALF) | negative |
2024.1.4 | Â |
 mNGS (BALF) | fusobacterium necrophorum |